Grand challenges in global health and the practical prevention program? Asian focus on cancer prevention in females of the developing world

Asian Pacific Journal of Cancer Prevention

Volumn 4, Issue 2, 2003, Pages 153-165

  Moore, Malcolm A ^a   Tajima, Kazuo ^b   Anh, Pham Hoang ^c   Aydemir, Gulsun ^d   Basu, Partha Sarathi ^e   Bhurgri, Yasmin ^f   Chen, Kexin ^g   Gajalakshmi, Vendhan ^h   Hirose, Kaoru ^b   Mosavi Jarrahi, Alireza ⁱ   Ngoan, Le Tran ^j   Qiao, You Lin ^k   Shin, Hai Rim ^l   Sriamporn, Supannee ^m   Srivatanakul, Petcharin ⁿ   Tokudome, Shinkan ^o   Yoo, Keun Young ^p   Tsuda, Hiroyuki ^q  

^a APOCP Coordination Center   (Japan)

^b AICHI CANCER CENTER HOSPITAL   (Japan)

^c National Cancer Institute   (Viet Nam)

^d EGE UNIVERSITY   (Turkey)

^e CHITTARANJAN NATIONAL CANCER INSTITUTE   (India)

^f JINNAH SINDH MEDICAL UNIVERSITY   (Pakistan)

^g KEY LABORATORY OF CANCER PREVENTION AND THERAPY   (China)

^h Epidemiological Research Center   (India)

ⁱ TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^j HANOI MEDICAL UNIVERSITY   (Viet Nam)

^k Cancer Hospital Institute   (China)

^l National Cancer Center   (South Korea)

^m KHON KAEN UNIVERSITY   (Thailand)

ⁿ NATIONAL CANCER INSTITUTE   (Thailand)

^o NAGOYA CITY UNIVERSITY   (Japan)

^p Seoul National University   (South Korea)

^q NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

more..

Author keywords

Diet in adolescence; HPV infection; Lifestyle; Major female cancers; Prevention; Research challenges

Indexed keywords

ARTICLE; ASIA; BREAST TUMOR; DEVELOPING COUNTRY; FEMALE; HUMAN; INTERNATIONAL COOPERATION; LIFESTYLE; RISK FACTOR; UTERINE CERVIX TUMOR;

ASIA; BREAST NEOPLASMS; DEVELOPING COUNTRIES; FEMALE; HUMANS; INTERNATIONAL COOPERATION; LIFE STYLE; RISK FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 0142245493     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Note

References (155)

1. Acladious NN, Sutton C, Mandal D, et al (2002). Persistent human papillomavirus infection and smoking increase risk of failure of treatment of cervical intraepithelial neoplasia (CIN). Int J Cancer, 98, 435-9.
2. Ahn Y-O (2001). Population-nased cancer registries in Korea. Asian Pacific J Cancer Prev, 2 (IACR Suppl), 39-42.
3. Anh PH (2001). Cancer registration in Vietnam. Asian Pacific J Cancer Prev, 2 (IACR Suppl), 85-9.
4. Anh PTH, Hieu NT, Herrero R, et al (2003). Human papillomavirus infection among women in South and North Vietnam. Int J Cancer, 104, 213-20.
5. Al Hamdan N, Bazarbashi S, Ajarim D, et al (2001). Cancer registration in Saudi Arabia. Asian Pacific J Cancer Prev, 2 (IACR Suppl), 61-4.
6. al-Lawati JA, al-Shaqsi, B N al-Siyabi (2001).Cancer registration in the Sultanate of Oman. Asian Pacific J Cancer Prev, 2 (IACR Suppl), 71-4.
7. Apter D (1996). Hormonal events during female puberty in relation to breast cancer risk. Eur J Cancer Prev, 5, 476-82.
8. Atkinson C, Bingham SA (2002). Mammographic breast density as a biomarker of effects of isoflavones on the female breast. Breast Cancer Res, 4, 1-4.
9. Bell MC, Crowley-Nowick P, Bradlow HL, et al (2000). Placebocontrolled trial of indole-3-carbinol in the treatment of CIN. Gynecol Oncol, 78, 123-9.
10. Bhurgri Y (2001). Cancer Registration in Pakistan. Asian Pacific J Cancer Prev, 2 (IACR Suppl), 51-4.
11. Boyd NF, Dite GS, Stone J, et al (2002). Heritability of mammographic density, a risk factor for breast cancer. N Engl J Med, 347, 886-94.
12. Brinton LA (1996). Hormones and risk of cancers of the breast and ovary Cancer Causes Control, 7, 569-71.
13. Brisson J, Brisson B, Cote G, et al (2000). Tamoxifen and mammographic breast densities. Cancer Epidemiol Biomarkers Prev, 9, 911-5.
14. Bruning PF, Bonfrer JM, van Noord PA, et al (1992). Insulin resistance and breast-cancer risk. Int J Cancer, 52, 511-6.
15. Castle PE, Hillier SL, Rabe LK, et al (2001). An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV). Cancer Epidemiol Biomarkers Prev, 10, 1021-7.
16. Chie WC, Chen CF, Lee WC, Chen CJ (1996). Body size and risk of pre- and post-menopausal breast cancer in Taiwan. Anticancer Research, 16, 3129-32.
17. Chirenje ZM, Chipato T, Kasule J, Rusakaniko S (1999). Visual inspection of the cervix as a primary means of cervical cancer screening: results of a pilot study. Cent Afr J Med, 45, 30-3.
18. Costa S, Sideri M, Syrjanen K, et al (2000). Combined Pap smear, cervicography and HPV DNA testing in the detection of cervical intraepithelial neoplasia and cancer. Acta Cytol, 44, 310-8.
19. Crum CP, Abbott DW, Quade BJ (2003). Cervical cancer screening: from the papanicolaou smear to the vaccine era. J Clin Oncol, 21 (10 Suppl), 224-30.
20. Deerasamee S, Martin N, Sontipong S, et al (2001). Cancer registration in Thailand. Asian Pacific J Cancer Prev, 2 (IACR Suppl), 79-84.
21. den Tonkelaar I, de Waard F (1996). Regularity and length of menstrual cycles in women aged 41-46 in relatior-to breast cancer risk: results from the DOM-project. Breast Cancer Res Treat, 38, 253-8.
22. Dietz W (1999). How to tackle the problem early? The role of education in the prevention of obesity. Int J Obes Relat Metab Disord, 23 (Suppl 4), S7-9.
23. DiPaolo JA, Popescu NC, Woodworth CD, Zimonjic DB (1996). Papillomaviruses and potential copathogens. Toxicol Lett, 88, 1-7.
24. Dzuba IG, Diaz EY, Allen B, et al (2002). The acceptability of self-collected samples for HPV testing vs. the Pap test as alternatives in cervical cancer screening. J Womens Health Gend Based Med, 11, 265-275.
25. Ebrahimi M, Vahdaninia M, Montazeri A (2002). Risk factors for breast cancer in Iran: a case-control study. Breast Cancer Res, 4, R10.
26. El-Bastawissi AY, White E, Mandelson MT, Taplin SH (2000). Reproductive and hormonal factors associated with mammographic breast density by age (United States). Cancer Causes Control, 11, 955-63.
27. El-Bastawissi AY, White E, Mandelson MT, Taplin S (2001). Variation in mammographic breast density by race. Ann Epidemiol, 11, 257-63.
28. Elfgren K, Jacobs M, Walboomers JM, Meijer CJ, Dillner J (2002). Rate of human papillomavirus clearance after treatment of cervical intraepithelial neoplasia. Obstet Gynecol, 100, 965-71.
29. Esteban DB, Laudico AV, Uy NA, Benabay L (2001). Cancer registration in the Philippines. Asian Pacific J Cancer Prev, 2 (IACR Suppl), 55-60.
30. Fidaner C, Eser SY, Parkin DM (2001). Incidence in Izmir in 1993-1994: first results from Izmir Cancer Registry. Eur J Cancer, 37, 83-92.
31. Follen M, Vlastos AT, Meyskens FL Jr, Atkinson EN, Schottenfeld D (2002).Why phase II trials in cervical chemoprevention are negative: what have we learned? Cancer Causes Control, 13, 855-73.
32. Franceschi S, Favero A, La Vecchia C, et al (1996). Body size indices and breast cancer risk before and after menopause. Int J Cancer, 67, 181-6.
33. Friedenreich CM, Rohan TE (1995). Physical activity and risk of breast cancer. Eur J Cancer Prev, 4, 145-51.
34. Gajalakshmi V (2000). Diet and cancers of the stomach, breast and lung. Asian Pacific J Cancer Prev, 1 (APCC Suppl), 39-43.
35. Gajalakshmi CK, Shantha V (1991). Risk factors for female breast cancer. A hospital-based case-control study in Madras, India. Acta Oncol, 30, 569-74.
36. Gajalakshmi V, Shantha V, Swaminathan R (2001). Cancer registration in India. Asian Pacific J Cancer Prev, 2 (IACR Suppl), 13-20.
37. Gajalakshmi CK, Shantha V, Hakama M (1998). Risk factors for contralateral breast cancer in Chennai (Madras). India Int J Epidemiol, 27, 743-50.
38. Ghim S-J, Basu PS, Jenson AB (2002) Cervical cancer: etiology, pathogenesis, treatment, and future vaccines. Asian Pacific J Cancer Prev, 3, 207-14.
39. Giuliano AR, Harris R, Sedjo RL, et al (2002a). Incidence, prevalence, and clearance of type-specific human papillomavirus infections: The Young Women's Health Study. J Infect Dis, 186, 462-9.
40. Giuliano AR, Papenfuss M, Abrahamsen M, Inserra P (2002b). Differences in factors associated with oncogenic and nononcogenic human papillomavirus infection at the United States-Mexico border. Cancer Epidemiol Biomarkers Prev, 11, 930-4.
41. Giuliano AR, Papenfuss M, Nour M, et al (1997). Antioxidant nutrients: associations with persistent human papillomavirus infection. Cancer Epidemiol Biomarkers Prev, 6, 917-23.
42. Giuliano AR, Sedjo RL, Roe DJ, et al (2002c). Clearance of oncogenic human papillomavirus (HPV) infection: effect of smoking (United States). Cancer Causes Control, 13, 839-46.
43. Gonzalez-Sanchez JL, Martinez-Chequer JC, Hernandez-Celaya ME, Barahona-Bustillos E, Andrade-Manzano AF (2001). Randomized placebo-controlled evaluation of intramuscular interferon beta treatment of recurrent human papillomavirus. Obstet Gynecol, 97, 621-4.
44. Goodman MT, Kiviat N, McDuffie K, et al (1998). The association of plasma micronutrients with the risk of cervical dysplasia in Hawaii. Cancer Epidemiol Biomarkers Prev.
45. Gravitt PE, Lacey JV Jr, Brinton LA, et al (2001). Evaluation of self-collected cervicovaginal cell samples for human papillomavirus testing by polymerase chain reaction. Cancer Epidemiol Biomarkers Prev, 10, 95-100.
46. Green J, Berrington De Gonzalez A, et al (2003). Human papillomavirus infection and use of oral contraceptives. Br J Cancer, 88, 1713-20.
47. Gudmundsdottir T, Tryggvadottir L, Allende M, et al (2003). Eligibility and willingness of young Icelandic women to participate in a HPV vaccination trial. Acta Obstet Gynecol Scand, 82, 345-50.
48. Hamajima N, Hirose K, Tajima K, et al (2002). Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer, 87, 1234-45.
49. Hamajima N, Takezaki T, Tajima K (2002). Allele Frequencies of 25 Polymorphisms Pertaining to Cancer Risk for Japanese, Koreans and Chinese. Asian Pacific J Cancer Prev, 3, 197-206.
50. Hao XS, Chen KS, Liu H (2002). Analysis of female breast cancer descriptive epidemiology in Tianjin, China. Asian Pac J Cancer Prev, 3, 143-8.
51. Harirchi I, Ebrahimi M, Zamani N, Jarvandi S, Montazeri A (2000). Breast cancer in Iran: a review of 903 case records. Public Health, 114, 143-5.
52. Hart BL, Steinbock RT, Mettler FA Jr, Pathak DR, Bartow SA (1989). Age and race related changes in mammographic parenchymal patterns. Cancer, 63, 25379
53. Henderson BE, Ross RK, Judd HL, et al (1985). Do regular ovulatory cycles increase breast cancer risk? Cancer, 56, 1206-8.
54. Hengge U R, Benninghoff B, Ruzicka T, Goos M (2001). Topical immunomodulators--progress towards treating inflammation, infection, and cancer. Lancet Infect Dis, 1, 189-98.
55. Hirose K, Tajima K, Hamajima N, et al (1995). A large-scale, hospital-based case-control study of risk factors of breast cancer according to menopausal status. Jpn J Cancer Res, 86, 146-54.
56. Hirose K, Tajima K, Hamajima N, et al (1999). Effect of body size on breast-cancer risk among Japanese women. Int J Cancer, 80, 349-55.
57. Hirose K, Hamajima N, Takezaki T, Miura S, Tajima K (2003). Physical exercise reduces risk of breast cancer in Japanese women. Cancer Sci, 94, 193-9.
58. Hirose K, Tajima K, Hamajima N, et al (2003b). Impact of established risk factors for breast cancer in nulligravid Japanese women. Breast Cancer, 10, 45-53.
59. Hirose K, Takezaki T, Hamajima N, Miura S, Tajima K (2003) Dietary factors protective against breast cancer in Japanese premenopausal and postmenopausal women. Int J Cancer (in press).
60. Ho GY, Palan PR, Basu J, et al (1998). Viral characteristics of human papillomavirus infection and antioxidant levels as risk factors for cervical dysplasia. Int J Cancer, 78, 594-9.
61. Hoover DR, Carfioli B, Moench EA (2000). Attitudes of adolescent/young adult women toward human papillomavirus vaccination and clinical trials. Health Care Women Int, 21, 375-91.
62. Hopfl R, Heim K, Christensen N, et al (2000). Spontaneous regression of CIN and delayed-type hypersensitivity to HPV-16 oncoprotein E7. Lancet, 356, 1985-6.
63. Hsieh CC, Trichopoulos D, Katsouyanni K, Yuasa S (1990). Age at menarche, age at menopause, height and obesity as risk factors for breast cancer: associations and interactions in an international case-control study [see comments]. Int J Cancer, 46, 796-800.
64. Inoue M, Tajima K, Mizutani M, et al (2001). Regular consumption of green tea and the risk of breast cancer recurrence: followup study from the Hospital-based Epidemiologic Research Program at Aichi Cancer Center (HERPACC), Japan. Cancer Lett, 167, 175-82.
65. Ito Y, Gajalakshmi KC, Sasaki R, Suzuki K, Shanta V (1999). A study on serum carotenoid levels in breast cancer patients of Indian women in Chennai (Madras), India. J Epidemiol, 9, 306-14
66. Jakes RW, Duffy SW, Ng FC, et al (2002). Mammographic parenchymal patterns and self-reported soy intake in Singapore Chinese women. Cancer Epidemiol Biomarkers Prev, 11, 608-13.
67. Kaaks R (1996). Nutrition, hormones, and breast cancer: is insulin the missing link? Cancer Causes Control, 7, 605-25.
68. Kadish AS, Timmins P, Wang Y, et al (2002). Regression of cervical intraepithelial neoplasia and loss of human papillomavirus (HPV) infection is associated with cellmediated immune responses to an HPV type 16 E7 peptide. Cancer Epidemiol Biomarkers Prev, 11, 483-8.
69. Kanetsky PA, Gammon MD, Mandelblatt J, et al (1998). Dietary intake and blood levels of lycopene: association with cervical dysplasia among non-Hispanic, black women. Nutr Cancer, 31, 31-40.
70. Kato I, Beinart C, Bleich A, et al (1995). A nested case-control study of mammographic patterns, breast volume, and breast cancer (New York City, NY, United States). Cancer Causes Control, 6, 431-8.
71. Kawana K, Yasugi T, Kanda T, et al (2002). Neutralizing antibodies against oncogenic human papillomavirus as a possible determinant of the fate of low-grade cervical intraepithelial neoplasia. Biochem Biophys Res Commun, 296, 102-5.
72. Kazer RR (1995). Insulin resistance, insulin-like growth factor I and breast cancer: a hypothesis. Int J Cancer, 62, 403-6.
73. Keefe KA, Schell MJ, Brewer C, et al (2001). A randomized, double blind, Phase III trial using oral beta-carotene supplementation for women with high-grade cervical intraepithelial neoplasia. Cancer Epidemiol Biomarkers Prev, 10, 1029-35.
74. Kjaer SK, van den Brule AJ, et al (2002). Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study. BMJ, 325, 572.
75. Klonoff-Cohen HS, Schaffroth LB, Edelstein SL, Molgaard C, Saltzstein SL (1998). Breast cancer histology in Caucasians, African Americans, Hispanics, Asians, and Pacific Islanders. Ethn Health, 3, 189-98.
76. Koutsky LA, Ault KA, Wheeler CM, et al (2002). A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med, 347, 1645-51.
77. Kruse AJ, Baak JP, Janssen EA, et al (2003). Low- and high-risk CIN 1 and 2 lesions: prospective predictive value of grade, HPV, and Ki-67 immuno-quantitative variables. J Pathol, 199, 462-70.
78. Kumar NB, Cantor A, Allen K, Riccardi D, Cox CE (2002). The specific role of isoflavones on estrogen metabolism in premenopausal women. Cancer, 94, 1166-74.
79. Kuroishi T, Hirose K, Suzuki T, Tominaga S (2000). Effectiveness of mass screening for breast cancer in Japan. Breast Cancer, 7, 1-8.
80. Lam PB, Vacek PM, Geller BM, Muss HB (2000). The association of increased weight, body mass index, and tissue density with the risk of breastcarcinoma in Vermont. Cancer, 89, 369-75.
81. Lazcano-Ponce E, Rivera L, et al (2001). Acceptability of a human papillomavirus (HPV) trial vaccine among mothers of adolescents in Cuernavaca, Mexico. Arch Med Res, 32,243-7.
82. Lehtinen M, Koskela P, Jellum E, et al (2002). Herpes simplex virus and risk of cervical cancer: a longitudinal, nested casecontrol study in the nordic countries. Am J Epidemiol, 156, 687-92.
83. Leung GM, Lam TH, Thach TQ, Hedley AJ (2002). Will screening mammography in the East do more harm than good? Am J Public Health, 92, 1841-6.
84. Li CI, Malone KE, White E, Daling JR (1997). Age when maximum height is reached as a risk factor for breast cancer among young U.S. women. Epidemiology, 8, 559-65.
85. Lu LJ, Anderson KE, Grady JJ, Kohen F, Nagamani M (2000). Decreased ovarian hormones during a soya diet: implications for breast cancer prevention.Cancer Res, 60, 4112-21.
86. Marcus PM, Newcomb PA, Storer BE (1994). Early adulthood physical activity and colon cancer risk among Wisconsin women. Cancer Epidemiol Biomarkers Prev, 3, 641-4.
87. Maskarinec G, Lyu LC, Meng L, Theriault A, Ursin G (2001). Determinants of mammographic densities among women of Asian, Native Hawaiian, and Caucasian ancestry. Ethn Dis, 11, 44-50.
88. Maskarinec G, Williams AE, Inouye JS, Stanczyk FZ, Franke AA (2002). A randomized isoflavone intervention among premenopausal women. Cancer Epidemiol Biomarkers Prev, 11, 195-201.
89. Merzenich H, Boeing H, Wahrendorf J (1993). Dietary fat and sports activity as determinants for age at menarche. Am J Epidemiol, 138, 217-24.
90. Mitchell MF, Hittelman WN, Lotan R, et al (1995). Chemoprevention trials in the cervix: design, feasibility, and recruitment. J Cell Biochem Suppl, 23, 104-12.
91. Mittendorf R, Longnecker MP, Newcomb PA, et al (1995). Strenuous physical activity in young adulthood and risk of breast cancer (United States).Cancer Causes Control, 6, 347-53.
92. Moore MA, Tajima K (2002). APOCP/APJCP report. Asian Pacific J Cancer Prev, 3, 283-8.
93. Moore MA, Tsuda H (1998). Proliferation as the key to cancer development. Eur J Cancer Prev, 7, 353-85.
94. Moreno V, Bosch FX, Munoz N, et al (2002). Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study. Lancet, 359, 1085-92.
95. Mosavi-Jarrahi A, Mohagheghi MA, Zeraatti H, Mortazavi H (2001). Cancer registration in Iran. Asian Pacific J Cancer Prev, 2 (IACR Suppl), 25-9.
96. Moseson M, Koenig KL, Shore RE, Pasternak BS (1993). The influence of medical conditions associated with hormones on the risk of breast cancer. Int J Epidemiol, 22, 1000-9.
97. Munkhtaivan A, Erdentuya S, Ozzi-Delger T (2001). Cancer Registration in Mongolia. Asian Pacific J Cancer Prev, 2 (IACR Suppl), 47-50.
98. Munoz N, Franceschi S, Bosetti C, et al (2002). Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study. Lancet, 359, 1093-101.
99. Nakao Y, Yang X, Yokoyama M, Pater MM, Pater A (1996). Malignant transformation of human ectocervical cells immortalized by HPV 18: in vitro model of carcinogenesis by cigarette smoke. Carcinogenesis, 17, 577-83.
100. Negri E, Braga C, La Vecchia C, et al (1996). Lactation and the risk of breast cancer in an Italian population. Int J Cancer, 67, 161-4.
101. Ohshima A, Tsukuma H, Ajiki W, for the Research group for Cancer Registration in Japan (2001). Cancer registration in Japan. Asian Pacific J Cancer Prev, 2 (IACR Suppl), 31-6.
102. Park WC, Jordan VC (2002). Selective estrogen receptor modulators (SERMS) and their roles in breast cancer prevention. Trends Mol Med, 8, 82-8.
103. Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J (Eds) (1997). Cancer Incidence in Five Continents Vol. VII. IARC Scientific Publications No 143. IARC, Lyon.
104. Pengsaa P, Vatanasapt V, Sriamporn S, et al (1997). A selfadministered device for cervical cancer screening in northeast Thailand. Acta Cytol, 41, 749-54.
105. Pike MC, Kolonel LN, Henderson BE, et al (2002).Breast cancer in a multiethnic cohort in Hawaii and Los Angeles: risk factoradjusted incidence in Japanese equals and in Hawaiians exceeds that in whites. Cancer Epidemiol Biomarkers Prev, 11, 795-800
106. Qasem MB (2001). Cancer Registration in Jordan. Asian Pacific J Cancer Prev, 2 (IACR Suppl), 37-8.
107. Rowland AS, Baird DD, Long S, et al (2002). Influence of medical conditions and lifestyle factors on the menstrual cycle. Epidemiology, 13, 668-74.
108. Rosemawati A, Sallehudin AB (2001). Cancer Registration in Malaysia. Asian Pacific J Cancer Prev, 2 (IACR Suppl), 43-5.
109. Russo J, Russo IH (1994). Toward a physiological approach to breast cancer prevention. Cancer Epidemiol Biomarkers Prev, 3, 353-64.
110. Sadler GR, Dhanjal SK, Shah NB, et al (2001). Asian Indian women: knowledge, attitudes and behaviors toward breast cancer early detection. Public Health Nurs, 18, 357-63.
111. Sarjadi, Padmi T (2001). Cancer Registration in Indonesia. Asian Pacific J Cancer Prev, 2 (IACR Suppl), 21-4.
112. Sankaranaraynan R, Wesley R, Somanthanan T, et al (1998). Visual inspection of the uterine cervix after the application of acetic acid in the detection of cervical carcinoma and its precursors. Cancer, 83, 2150-6.
113. Schiffman M, Wheeler CM, Castle PE (2002). Atypical Squamous Cells of Undetermined Significance/Low-grade Squamous Intraepithelial Lesion Triage Study Group. Human papillomavirus DNA remains detectable longer than related cervical cytologic abnormalities. J Infect Dis, 186, 1169-72.
114. Sedjo RL, Inserra P, Abrahamsen M, et al (2002). Human papillomavirus persistence and nutrients involved in the methylation pathway among a cohort of young women. Cancer Epidemiol Biomarkers Prev, 11, 353-9.
115. Sellors JW, Karwalajtys TL, Kaczorowski J, et al (2003). Incidence, clearance and predictors of human papillomavirus infection in women. CMAJ, 168, 421-5.
116. Shannon J, Thomas DB, Ray RM, et al (2002). Dietary risk factors for invasive and in-situ cervical carcinomas in Bangkok, Thailand. Cancer Causes Control, 13, 691-9.
117. Shimizu H, Ross RK, Bernstein L, et al (1991). Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County. Br J Cancer, 63, 963-6.
118. Shin HR, Lee DH, Herrero R, et al (2003). Prevalence of human papillomavirus infection in women in Busan, South Korea. Int J Cancer, 103, 413-21.
119. Shu XO, Jin F, Dai Q, et al Soyfood intake during adolescence and subsequent risk of breast cancer among Chinese women. Cancer Epidemiol Biomarkers Prev. 2001 May;10(5):483-8.
120. Siddiqui MS, Kayani N, Sulaiman S, et al (2000). Breast carcinoma in Pakistani females: a morphological study of 572 breast specimens. J Pak Med Assoc, 50, 174-7.
121. Singh V, Sehgal A, Parashari A, Sodhani P, Satyanarayana L (2001). Early detection of cervical cancer through acetic acid application--an aided visual inspection. Singapore Med J, 42, 351-4.
122. Smith JS, Herrero R, Bosetti C, et al (2002a). Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer. J Natl Cancer Inst, 94, 1604-13.
123. Smith JS, Munoz N, Herrero R, et al (2002b). Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines. J Infect Dis, 185, 324-31.
124. Snoeck R, Andrei G, De Clercq E (2001). Cidofovir in the treatment of HPV-associated lesions. Verh K Acad Geneeskd Belg, 63, 93-120, discussion 120-2.
125. Stoll BA (1996). Obesity and breast cancer. Int J Obes Related Metabolic Disord, 20, 389-92.
126. Suh JS, Yoo KY, Kwon OJ, et al (1996). Menstrual and reproductive factors related to the risk of breast cancer in Korea. Ovarian hormone effect on breast cancer. J Korean Med Sci, 11, 501-8.
127. Suh-Burgmann E, Sivret J, Duska LR, Del Carmen M, Seiden MV (2003). Long-term administration of intravaginal dehydroepiandrosterone on regression of low-grade cervical dysplasia - a pilot study. Gynecol Obstet Invest, 55, 25-31.
128. Tajima K, Moore MA (2001). Risk and beneficial factors - fallacy at the individual but not the population level? Relevance to a Practical Prevention Program. Asian Pacific J Cancer Prev, 2, 83-7.
129. Tajima K, Moore MA (2002). Programs for Asian Pacific cancer prevention in response to the four strategic directions of UICC for the millennium. Asian Pacific J Cancer Prev, 3, 263-6.
130. Thomas DB, Ray RM, Koetsawang A, et al (2001). Human papillomaviruses and cervical cancer in Bangkok. I. Risk factors for invasive cervical carcinomas with human papillomavirus types 16 and 18 DNA. Am J Epidemiol, 153, 723-31.
131. Thurfjell E, Hsieh CC, Lipworth L, et al (1996). Breast size and mammographic pattern in relation to breast cancer risk. Eur J Cancer Prev, 5, 37-41.
132. Tran-Thanh D, Provencher D, Koushik A, et al (2003). Herpes simplex virus type II is not a cofactor to human papillomavirus in uterine cervix cancer. Am J Obstet Gynecol, 188, 129-34.
133. Tretli S, Gaard M (1996). Lifestyle changes during adolescence and risk of breast cancer: an ecologic study of the effect of World War II in Norway. Cancer Causes Control, 7, 507-12.
134. Tsuda H, Naito A, Kim C-K, et al (2003). Carcinogenesis and its modification by environmental endocrine disruptors - in vivo experimental and epidemiological findings. Jpn J Clin Oncol, (in press).
135. Türkistanli{dotless} EC, Sogukpi{dotless}nar N, Saydam BK, Aydemir G (2003). Cervical cancer prevention and early detection; the role of nurse and midwives. Asian Pacific J Cancer Prev, 4, 39-44.
136. Ursin G, Ma H, Wu AH, et al (2003). Mammographic density and breast cancer in three ethnic groups. Cancer Epidemiol Biomarkers Prev, 12, 332-8.
137. van Duin M, Snijders PJ, Schrijnemakers HF, et al (2002). Human papillomavirus 16 load in normal and abnormal cervical scrapes: an indicator of CIN II/III and viral clearance. Int J Cancer, 98, 590-5.
138. Van Noord PA, Haars G, Peeters PH (2002). Age at exposure to the Dutch famine of 1944-1945 has opposing effects on adult mammographic density (DY); a study in the DOM cohort. IARC Sci Publ, 156, 541-2.
139. Velema JP, Ferrera A, Figueroa M, et al (2002). Burning wood in the kitchen increases the risk of cervical neoplasia in HPVinfected women in Honduras. Int J Cancer, 97, 536-41.
140. Wakai K, Dillon DS, Ohno Y, et al (2000). Fat intake and breast cancer risk in an area where fat intake is low: a case-control study in Indonesia. Int J Epidemiol, 29, 20-8.
141. Wang Q (2001). Cancer Registration in China. Asian Pacific J Cancer Prev, 2 (IACR Suppl), 3-8.
142. Wesley R, Sankaranarayanan R, Mathew B, et al (1997). Evaluation of visual inspection as a screening test for cervical cancer. Br J Cancer, 75, 436-40.
143. White E, Velentgas P, Mandelson MT, et al (1998). Variation in mammographic breast density by time in menstrual cycle among women aged 40-49. J Natl Cancer Inst, 90, 906-10
144. Wu AH, Ziegler RG, Pike MC, et al (1996). Menstrual and reproductive factors and risk of breast cancer in Asian-Americans. British Journal of Cancer, 73, 680-6.
145. Wu AH, Stanczyk FZ, Seow A, Lee HP, Yu MC (2002). Soy intake and other lifestyle determinants of serum estrogen levels among postmenopausal Chinese women in Singapore.Cancer Epidemiol Biomarkers Prev, 11, 844-51.
146. Xu X, Duncan AM, Wangen KE, Kurzer MS (2000). Soy consumption alters endogenous estrogen metabolism in postmenopausal women. Cancer Epidemiol Biomarkers Prev, 9, 781-6.
147. Yajnik C (2000). Interactions of perturbations in intrauterine growth and growth during childhood on the risk of adult-onset disease. Proc Nutr Soc, 59, 257-65.
148. Yeole BB, Kurkure AP (2003). An epidemiological assessment of increasing incidence and trends in breast cancer in Mumbai and other sites in India, during the last two decades. Asian Pacific J Cancer Prev, 4, 51-6.
149. Yoo KY, Kang D, Park SK, et al (2002). Epidemiology of breast cancer in Korea: occurrence, high-risk groups, and prevention. J Korean Med Sci, 17, 1-6.
150. Yoo KY, Kim H, Shin HR, et al (1998). Female sex hormones and body mass in adolescent and postmenopausal Korean women. J Korean Med Sci, 13, 241-6.
151. Yoo KY, Tajima K, Kuroishi T, et al (1992). Independent protective effect of lactation against breast cancer: a case-control study in Japan. Am J Epidemiol, 135, 726-33.
152. Yoo K, Tajima K, Park S, et al (2001). Postmenopausal obesity as a breast cancer risk factor according to estrogen and progesterone receptor status (Japan). Cancer Lett, 167, 57-63.
153. Ziegler RG (1997). Anthropometry and breast cancer. J Nutrition, 127(5 Suppl), 924S-8S.
154. Ziv E, Shepherd J, Smith-Bindman R, Kerlikowske K (2003). Mammographic breast density and family history of breast cancer. J Natl Cancer Inst, 95, 556-8.
155. Zur Hausen H (2002). Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer, 2, 342-50.